1. Newman L, Rowley J, Vander Hoorn S, Wijesooriya NS, Unemo M, Low N, et al. Global estimates of the prevalence and incidence of four curable sexually transmitted infections in 2012 based on systematic review and global reporting. PloS one. 2015;10(12):e0143304. [
DOI:10.1371/journal.pone.0143304]
2. Lusk MJ, Konecny P. Cervicitis: a review. Current opinion in infectious diseases. 2008;21(1):49-55. [
DOI:10.1097/QCO.0b013e3282f3d988]
3. Manhart LE, Critchlow CW, Holmes KK, Dutro SM, Eschenbach DA, Stevens CE, et al. Mucopurulent cervicitis and Mycoplasma genitalium. The Journal of infectious diseases. 2003;187(4):650-7. [
DOI:10.1086/367992]
4. Ujević B, Habek J, Habek D. Prevalence of infection with Neisseria gonorrhoeae or Chlamydia trachomatis in acute mucopurulent cervicitis. Archives of Industrial Hygiene and Toxicology. 2009;60(2):197-203. [
DOI:10.2478/10004-1254-60-2009-1916]
5. Marrazzo JM, Martin DH. Management of women with cervicitis. Clinical infectious diseases. 2007;44(Supplement_3):S102-S10.
6. Da Ros CT, da Silva Schmitt C. Global epidemiology of sexually transmitted diseases. Asian journal of andrology. 2008;10(1):110-4. [
DOI:10.1111/j.1745-7262.2008.00367.x]
7. McCormack WM, Augenbraun MH. Vulvovaginitis and cervicitis. Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases (Eighth Edition): Elsevier; 2015. p. 1358-71. e2.
8. Marrazzo JM, Wiesenfeld HC, Murray PJ, Busse B, Meyn L, Krohn M, et al. Risk factors for cervicitis among women with bacterial vaginosis. The Journal of infectious diseases. 2006;193(5):617-24. [
DOI:10.1086/500149]
9. Wen D, Lan D. The newly diagnosis and treatment strategy for the chronic cervicitis [J]. Chinese Journal of Practical Gynecology and Obstetrics. 2008;1:002.
10. Aletaha S, AKya A, Salimi A, Ahmadi K. The Frequency of Herpes Simplex Type 2 Infection in Women with Cervicitis in Kermanshah city in 2011. Journal of Zanjan University of Medical Sciences & Health Services. 2014;22(92).
11. Naji EN. Cytological and Microbial Investigation of Cervicitisby Endocervical Cytobrushe Smear in Some Iraqi Women Patients. Journal of Global Pharma Technology. 2018.
12. Khajehkarramedini M, Hashemi SA, Naderinasab M, Meshkat Z, AmelJamehdar S. Frequency of Chlamydia trachomatis infection in cervical and urethral samples referred to Ghaem Hospital of Mashhad. The Iranian Journal of Obstetrics, Gynecology and Infertility. 2011;13(6):17-21.
13. Taylor SN, Lensing S, Schwebke J, LillisR, Mena LA, Nelson AL, et al. Prevalence and treatment outcome of cervicitis of unknown etiology. Sexually transmitted diseases. 2013;40(5). [
DOI:10.1097/OLQ.0b013e31828bfcb1]
14. Menéndez C, Castellsagué X, Renom M, Sacarlal J, Quintó L, Lloveras B, et al. Prevalence and risk factors ofsexually transmitted infections and cervical neoplasia in women from a rural area of southern Mozambique. Infectious diseases in obstetrics and gynecology. 2010;2010.
15. YongJun G, Juntai W, Hui D. Analysis on Census Results for Married Women Cervicitisin 5605 Cases. Chinese Journal of Medicinal Guide. 2012;1:023.
16. Fonck K, Kidula N, Jaoko W, Estambale B, Claeys P, Ndinya-Achola J, et al. Validity of the vaginal discharge algorithm among pregnant and non-pregnant women in Nairobi, Kenya. Sexually transmitted infections. 2000;76(1):33-8. [
DOI:10.1136/sti.76.1.33]
17. Kyriakis KP, Hadjivassiliou M, Paparizos VA, Flemetakis A, Stavrianeas N, Katsambas A. Incidence determinants of gonorrhea, chlamydial genital infection, syphilis and chancroid in attendees at a sexually transmitted disease clinic in Athens, Greece. International journal of dermatology. 2003;42(11):876-81. [
DOI:10.1046/j.1365-4362.2003.01737.x]